Chan S-Y, Franklyn J A, Pemberton H N, Bulmer J N, Visser T J, McCabe C J, Kilby M D
Department of Fetal Medicine, Division of Reproductive & Child Health, University of Birmingham, Edgbaston, Birmingham B15 2TG, UK.
J Endocrinol. 2006 Jun;189(3):465-71. doi: 10.1677/joe.1.06582.
Thyroid hormones (THs) are essential for normal fetal development, with even mild perturbation in maternal thyroid status in early pregnancy being associated with neurodevelopmental delay in children. Transplacental transfer of maternal THs is critical, with increasing evidence suggesting a role for 3,3',5-tri-iodothyronine (T3) in development and function of the placenta itself, as well as in development of the central nervous and other organ systems. Intrauterine growth restriction (IUGR) is associated with fetal hypothyroxinaemia, a factor that may contribute to neurodevelopmental delay. The recent description of monocarboxylate transporter 8 (MCT8) as a powerful and specific TH membrane transporter, and the association of MCT8 mutations with profound neurodevelopmental delay, led us to explore MCT8 expression in placenta. We describe the expression of MCT8 in normal human placenta throughout gestation, and in normal third-trimester placenta compared with that associated with IUGR using quantitative reverse transcriptase PCR. MCT8 mRNA was detected in placenta from early first trimester, with a significant increase with advancing gestation (P=0.007). In the early third trimester, MCT8 mRNA was increased in IUGR placenta compared with normal samples matched for gestational age (P<0.05), but there was no difference between IUGR and normal placenta in the late third trimester. Western immunoblotting findings in IUGR and normal placentae were in accord with mRNA data. MCT8 immunostaining was demonstrated in villous cytotrophoblast and syncytiotrophoblast as well as extravillous trophoblast cells from the first trimester onwards with increasingly widespread immunoreactivity seen with advancing gestation. In conclusion, expression of MCT8 in placenta from early gestation is compatible with an important role in TH transport during fetal development and a specific role in placental development. Altered expression in placenta associated with IUGR may reflect a compensatory mechanism attempting to increase T3 uptake by trophoblast cells.
甲状腺激素(THs)对胎儿的正常发育至关重要,即使孕早期母体甲状腺状态出现轻微紊乱也与儿童神经发育迟缓有关。母体THs的胎盘转运至关重要,越来越多的证据表明3,3',5-三碘甲状腺原氨酸(T3)在胎盘自身的发育和功能以及中枢神经和其他器官系统的发育中发挥作用。宫内生长受限(IUGR)与胎儿甲状腺素血症有关,这一因素可能导致神经发育迟缓。最近,单羧酸转运蛋白8(MCT8)被描述为一种强大而特异的TH膜转运蛋白,且MCT8突变与严重神经发育迟缓相关,这促使我们探究MCT8在胎盘中的表达。我们使用定量逆转录聚合酶链反应描述了MCT8在整个妊娠期正常人类胎盘中的表达,并将妊娠晚期正常胎盘与IUGR相关胎盘的表达进行了比较。在妊娠早期即可在胎盘中检测到MCT8 mRNA,且随着孕周增加显著升高(P = 0.007)。在妊娠晚期早期,与孕周匹配的正常样本相比,IUGR胎盘的MCT8 mRNA增加(P < 0.05),但在妊娠晚期IUGR胎盘与正常胎盘之间无差异。IUGR胎盘和正常胎盘的蛋白质免疫印迹结果与mRNA数据一致。从妊娠早期开始,在绒毛细胞滋养层、合体滋养层以及绒毛外滋养层细胞中均检测到MCT8免疫染色,且随着孕周增加免疫反应性越来越广泛。总之,妊娠早期胎盘中MCT8的表达与胎儿发育过程中TH转运的重要作用以及胎盘发育的特定作用相符。与IUGR相关的胎盘表达改变可能反映了一种试图增加滋养层细胞T3摄取的代偿机制。